To hear about similar clinical trials, please enter your email below

Trial Title: Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

NCT ID: NCT05496972

Condition: Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Conditions: Official terms:
Neoplasms

Study type: Observational

Overall status: Active, not recruiting

Study design:

Time perspective: Cross-Sectional

Intervention:

Intervention type: Behavioral
Intervention name: Survey Administration
Description: Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine
Arm group label: Telemedicine Visits

Summary: To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.

Detailed description: Primary Objective: To characterize patient and provider satisfaction with telemedicine in RO Secondary Objective: - To provide evidence for or against the use of telemedicine in radiation oncology (RO) - To assess the feasibility of and value added by telemedicine in RO - To describe barriers and facilitators to telemedicine in RO - To identify preferred use cases for telemedicine in RO

Criteria for eligibility:

Study pop:
MD Anderson Cancer Center

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations - English speaking - Access to email and internet to complete the survey - Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience Exclusion Criteria: • Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: MD Anderson Cancer Center

Address:
City: Houston
Zip: 77030
Country: United States

Start date: April 21, 2021

Completion date: July 1, 2027

Lead sponsor:
Agency: M.D. Anderson Cancer Center
Agency class: Other

Source: M.D. Anderson Cancer Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05496972
http://www.mdanderson.org

Login to your account

Did you forget your password?